AVEO Oncology
AVEO
#7394
Rank
S$0.67 B
Marketcap
S$19.37
Share price
0.00%
Change (1 day)
167.69%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -S$39.88 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are S$94.31 Million. In 2021 the company made an earning of -S$68.88 Million a decrease over its 2020 earnings that were of -S$45.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -S$39.88 Million-42.11%
2021 -S$68.88 Million49.9%
2020 -S$45.95 Million-479.04%
2019 S$12.12 M-276.17%
2018 -S$6.89 Million-91.79%
2017 -S$83.83 Million142.38%
2016 -S$34.59 Million78.51%
2015 -S$19.38 Million-71.55%
2014 -S$68.1 Million-50.72%
2013 -S$0.14 Billion-4.88%
2012 -S$0.15 Billion-426.29%
2011 S$44.52 M-159.85%
2010 -S$74.41 Million35.33%
2009 -S$54.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
S$44.89 B-119,832.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$14.27 B-38,159.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$0.57 B-1,632.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$7.34 B-19,683.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.63 B-39,123.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-S$2.92 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA